Therapies such as IPI (Ipilimumab) and Yervoy, that act to put the brakes on tumor growth by becoming an immune booster. It blocks a protein called CTLA-4 that acts as a brake on T cells, the soldiers of the immune system. Approved by the FDA in March 2011 for use in Stage IV patients.
Melanoma Patients Australia recognises Aboriginal and Torres Strait Islander Peoples as the Traditional Owners and Custodians of Australia, and we acknowledge, respect and embrace their continued connection to land, waters and community. We pay our respect to all Aboriginal and Torres Strait Islander Elders past, present and emerging.
We recognise, value and celebrate diversity and act in the spirit of inclusion.
